financetom
ROVR
financetom
/
Consumer Discretionary
/
ROVR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Rover Group, Inc.ROVR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
2.00B
Revenue (ttm)
217.80M
Net Income (ttm)
10.86M
Shares Out
181.81M
EPS (ttm)
0.05
PE Ratio
219.80
Forward PE
77.76
Dividend
n/a
Ex-Dividend Date
n/a
Volume
2,163,226
Open
10.99
Previous Close
10.99
Day's Range
10.99 - 11.00
52-Week Range
3.83 - 11.10
Beta
1.94
Analysts
Buy
Price Target
8.05 (-26.75%)
Earnings Date
Mar 12, 2024
Description >

Rover Group, Inc. operates an online marketplace for pet care worldwide.

It connects pet parents with pet providers who offer overnight services, including boarding and in-home pet sitting, as well as daytime services, such as doggy daycare, dog walking, drop-in visits, grooming, and training.

The company was founded in 2011 and is headquartered in Seattle, Washington.

Latest News >
Honda Motor's Fiscal Q1 Profit, Sales Rise
Honda Motor's Fiscal Q1 Profit, Sales Rise
Aug 7, 2024
06:17 AM EDT, 08/07/2024 (MT Newswires) -- Honda Motor Company ( HMC ) reported fiscal Q1 earnings Wednesday of 81.81 Japanese yen ($0.56) per share, up from 73.02 yen per share a year earlier. Three analysts polled by Capital IQ expected 78.16 yen. Sales for the quarter ended June 30 were 5.405 trillion yen, up from 4.625 trillion yen a...
Organigram Says Product Development Collaboration Completes Clinical Study on Nanoemulsion Technology
Organigram Says Product Development Collaboration Completes Clinical Study on Nanoemulsion Technology
Aug 7, 2024
06:22 AM EDT, 08/07/2024 (MT Newswires) -- Organigram Holdings ( OGI ) , a licensed producer of cannabis, released the preliminary results of a clinical pharmacokinetic (PK) study conducted via the Product Development Collaboration (PDC) on its latest innovation, nanoemulsion technology. A statement said this patent-pending technology, branded FASTTM (Fast Acting Soluble Technology), will be the first innovation to be...
Coca-Cola Europacific Partners' Fiscal H1 Comparable Earnings, Revenue Rise
Coca-Cola Europacific Partners' Fiscal H1 Comparable Earnings, Revenue Rise
Aug 7, 2024
06:23 AM EDT, 08/07/2024 (MT Newswires) -- Coca-Cola Europacific Partners ( CCEP ) reported fiscal first-half comparable earnings Wednesday of 1.97 euros ($2.15) per diluted share, up from 1.85 euros a year earlier. Three analysts polled by Capital IQ expected 1.94 euros. Revenue for the half that ended June 28 was 9.83 billion euros, up from 8.98 billion euros a...
Novo Nordisk Tumbles 3% In Wednesday Premarket: What's Causing 'Miracle' Weight Loss Drug Ozempic Maker's Stock Slide?
Novo Nordisk Tumbles 3% In Wednesday Premarket: What's Causing 'Miracle' Weight Loss Drug Ozempic Maker's Stock Slide?
Aug 7, 2024
Shares of Novo Nordisk ( NVO ) , the pharmaceutical giant behind “miracle” weightloss drugs Ozempic and Wegovy, took a hit in pre-market trading on Wednesday, following the announcement of its second-quarter results, which fell short of expectations. The company also revised its operating profit outlook downwards. What Happened: Novo Nordisk’s shares dipped by 2.94% in pre-market trading after the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved